J. Lipid Res.  Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on December 1, 2007

Papers In Press, published online ahead of print September 22, 2007
J. Lipid Res., doi:10.1194/jlr.M700176-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M700176-JLR200v1
48/12/2640    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Leuven, S. I.
Right arrow Articles by Hommes, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Leuven, S. I.
Right arrow Articles by Hommes, D. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on April 10, 2007
Revised on September 19, 2007
Accepted on September 21, 2007

Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease

Sander I. van Leuven, Rachel Hezemans, Johannes H. M. Levels, Susanne Snoek, Pieter C. Stokkers, G. Kees Hovingh, John J. P. Kastelein, Erik S. Stroes, Eric de Groot, and Daan W. Hommes

Vascular Medicine, Academic Medical Centre, Amsterdam 1105 AZ

Corresponding Author: s.i.vanleuven{at}amc.uva.nl

Background: A chronic inflammatory state is a risk factor for accelerated atherogenesis. The aim of our study was to explore whether Crohn’s disease (CD), characterized by recurrent inflammatory episodes, is also associated with accelerated atherogenesis. Methods: In 60 CD patients and 122 matched controls, carotid intima media thickness (IMT), a validated marker for the burden and progression of atherosclerosis, was assessed ultrasonographically. Additional subgroup analyses including plasma levels of acute phase reactants and HDL protein profiling were performed in 11 consecutive patients with CD in remission, 10 patients with active CD and 15 healthy controls. Results: Carotid IMT in patients with CD was increased compared to healthy volunteers; 0.71 (0.17) versus 0.59 (0.14) mm (p<0.0001), respectively. In the subgroup analysis, HDL levels in controls and patients in remission were identical ((1.45 (0.48) and 1.40 (0.46)mmol/L: p=0.797), whereas HDL during exacerbation was profoundly reduced; 1.02 (0.33): p=0.022. HDL from patients with active CD and CD patients in remission was characterized by a reduced ability to attenuate oxidation compared to controls (p=0.008 and p=0.024 respectively). Conclusions: Patients with CD have increased IMT compared to matched controls, indicative of accelerated atherogenesis. The changes during CD exacerbation in terms of both HDL concentration as well as composition imply a role for impaired HDL protection in these patients.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.